Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.24%
1,103.05
+2.67
+0.24%
—1,100.381,096.191,112.971,094.08——
SIXC
Communications
SIXC
Communications
SIXC
+0.19%
622.42
+1.21
+0.19%
—621.21621.21624.47618.56——
SIXE
Energy
SIXE
Energy
SIXE
-2.87%
1,157.44
-34.22
-2.87%
—1,191.661,158.281,160.761,124.17——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.82%
1,750.30
+31.25
+1.82%
—1,719.051,729.911,766.941,729.91——
SIXM
Financials
SIXM
Financials
SIXM
+0.75%
646.61
+4.84
+0.75%
—641.77643.39653.21643.39——
SIXR
Staples
SIXR
Staples
SIXR
+1.26%
833.78
+10.40
+1.26%
—823.38822.99834.38820.61——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.54%
218.49
+3.31
+1.54%
—215.18215.18218.76215.18——
SIXT
Technology
SIXT
Technology
SIXT
+1.50%
3,109.02
+45.83
+1.50%
—3,063.193,096.933,118.043,093.29——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.42%
935.18
-3.92
-0.42%
—939.10937.35937.41924.95——
SIXV
Health care
SIXV
Health care
SIXV
+1.45%
1,503.60
+21.56
+1.45%
—1,482.041,485.591,506.801,485.59——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+2.36%
2,435.30
+56.09
+2.36%
—2,379.212,409.512,463.802,409.51——
Regeneron Pharmaceuticals Inc
€654.30
+2.81%
(+17.90) 1D
Apr 7, 3:16:51 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1REGN...
Mkt. cap
79.35B
Avg. vol.
6.00
Volume
0.00
52-wk high
€697.00
52-wk low
€418.00
No. of employees
15K
News stories
From sources across the web
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc
CEOLeonard Schleifer
Employees15.4K
Founded1988
HeadquartersTarrytown, New York, United States
SectorBiotechnology
Websiteregeneron.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
3.03B
3.68B
3.75B
3.88B
Cost of goods sold
1.79B
1.95B
2.00B
2.21B
Cost of revenue
1.79B
1.95B
2.00B
2.21B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
633.00M
634.20M
657.80M
775.00M
Operating expense
633.00M
634.20M
647.80M
775.00M
Total operating expenses
2.42B
2.59B
2.64B
2.99B
Operating income
604.00M
1.09B
1.11B
898.60M
Other non operating income
8.80M
18.20M
3.00M
958.50M
EBT including unusual items
905.00M
1.52B
1.76B
1.04B
EBT excluding unusual items
777.60M
1.28B
1.27B
2.04B
Income tax expense
96.30M
127.10M
303.30M
199.10M
Effective tax rate
10.64%
8.37%
17.20%
19.08%
Other operating expenses
-
-
-10.00M
-
Net income
808.70M
1.39B
1.46B
844.60M
Net profit margin
26.70%
37.86%
38.89%
21.74%
Earnings per share
8.22
12.89
11.83
11.44
Interest and investment income
173.50M
174.80M
175.10M
193.30M
Interest expense
-8.70M
-3.60M
-19.30M
-12.20M
Net interest expenses
164.80M
171.20M
155.80M
181.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
730.90M
1.22B
1.25B
1.04B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer